Loading chat...
WV HB4984
Bill
Status
Introduced
1/30/2026
Primary Sponsor
Evan Worrell
Click for details
AI Summary
- Prohibits prior authorization requirements and utilization management controls on FDA-approved antipsychotic medications under West Virginia's fee-for-service and managed care Medicaid programs
- Aims to remove barriers to timely treatment of serious mental illness by eliminating administrative hurdles for antipsychotic prescriptions
- Amends existing prior authorization law (§9-5-32) administered by the Bureau for Medical Services
- Maintains existing prior authorization portal requirements and procedures for other medications and services, including the comprehensive drug list and step therapy protocols
- Introduced January 30, 2026, and referred to the House Committee on Health and Human Resources
Legislative Description
Generic use of antipsychotics in Medicaid
Human Services
Last Action
Markup Discussion
2/18/2026
Committee Referrals
Health & Human Resources1/30/2026
Full Bill Text
No bill text available